Learn More
PURPOSE To compare standardized visual outcomes and macular thickness changes associated with primary and secondary bevacizumab (Avastin; Genentech, Inc., South San Francisco, CA) therapy for(More)
PURPOSE To assess the efficacy of bioresorbable mesh in reconstruction of orbitocranial deformities. METHODS A retrospective case series evaluating 6 orbits of 6 patients, ages 12 to 70 years old,(More)
  • 1